FR2513881A2 - Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant - Google Patents

Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant Download PDF

Info

Publication number
FR2513881A2
FR2513881A2 FR8118647A FR8118647A FR2513881A2 FR 2513881 A2 FR2513881 A2 FR 2513881A2 FR 8118647 A FR8118647 A FR 8118647A FR 8118647 A FR8118647 A FR 8118647A FR 2513881 A2 FR2513881 A2 FR 2513881A2
Authority
FR
France
Prior art keywords
mjh
substance
substances
immunostimulants
sephadex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8118647A
Other languages
English (en)
French (fr)
Other versions
FR2513881B2 (enExample
Inventor
Pierre Jolles
Daniele Migliore-Samour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8021292A external-priority patent/FR2491334A1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR8118647A priority Critical patent/FR2513881A2/fr
Publication of FR2513881A2 publication Critical patent/FR2513881A2/fr
Application granted granted Critical
Publication of FR2513881B2 publication Critical patent/FR2513881B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8118647A 1980-10-03 1981-10-02 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant Granted FR2513881A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8118647A FR2513881A2 (fr) 1980-10-03 1981-10-02 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8021292A FR2491334A1 (fr) 1980-10-03 1980-10-03 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR8118647A FR2513881A2 (fr) 1980-10-03 1981-10-02 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant

Publications (2)

Publication Number Publication Date
FR2513881A2 true FR2513881A2 (fr) 1983-04-08
FR2513881B2 FR2513881B2 (enExample) 1984-01-06

Family

ID=26222011

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8118647A Granted FR2513881A2 (fr) 1980-10-03 1981-10-02 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant

Country Status (1)

Country Link
FR (1) FR2513881A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2559157A1 (fr) * 1984-02-07 1985-08-09 Inst Nat Sante Rech Med Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
FR2565985A1 (fr) * 1984-06-19 1985-12-20 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
BE1010300A3 (fr) * 1996-05-22 1998-05-05 Personnalite Juridique De La S Procede de preparation de peptides exempts de phenylalanine.

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2559157A1 (fr) * 1984-02-07 1985-08-09 Inst Nat Sante Rech Med Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
EP0155199A1 (fr) * 1984-02-07 1985-09-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nouvel héxapeptide,son procédé d'obtention et les compositions pharmaceutiques qui le contiennent
FR2565985A1 (fr) * 1984-06-19 1985-12-20 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
EP0170550A1 (fr) * 1984-06-19 1986-02-05 Rhone-Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procédé de preparation et les compositions qui les contiennent
US4777243A (en) * 1984-06-19 1988-10-11 Rhone Poulenc Sante, French Body Corporate Immuno stimulant substances derived from bovine casein and compositions containing the same
BE1010300A3 (fr) * 1996-05-22 1998-05-05 Personnalite Juridique De La S Procede de preparation de peptides exempts de phenylalanine.

Also Published As

Publication number Publication date
FR2513881B2 (enExample) 1984-01-06

Similar Documents

Publication Publication Date Title
EP0049666B1 (fr) Nouvelles substances biologiquement actives, leur obtention à partir de caséine humaine et compositions les contenant
EP1326636B1 (fr) Composition vaccinale
EP1042363B1 (fr) Nouveaux immunogenes anti-hiv (toxoides), procedes de preparation et application a la prevention et au traitement du sida
US5756449A (en) Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease
EP0170550B1 (fr) Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procédé de preparation et les compositions qui les contiennent
EP1181314A1 (fr) FRAGMENTS PROTEIQUES POLYEPITOPIQUES DE LA PROTEINE Nef DE HIV, LEUR OBTENTION ET LEURS UTILISATIONS NOTAMMENT EN VACCINATION
EP0814834B1 (fr) Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps diriges contre ces immunogenes, procede pour leur preparation et compositions pharmaceutiques les renfermant
EP0015810B1 (fr) N-acétyl-L-(N-méthyl-alanyl)-D-isoglutamine et compositions la contenat, pour l'utilisation en tant que régulateurs des mécanismes immunitaires
FR2513881A2 (fr) Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
EP0165123B1 (fr) Dérivés lipophiles de muramylpeptides ayant des propriétés d'activation des macrophages, compositions les contenant et procédé pour les obtenir
US6011014A (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
EP0174245B1 (fr) Nouveaux medicaments contenant des tripeptides
EP0155199B1 (fr) Nouvel héxapeptide,son procédé d'obtention et les compositions pharmaceutiques qui le contiennent
AU725680B2 (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
EP0169115A1 (fr) Nouvelles substances immunologiquement actives, leur procédé de préparation à partir du fibrinogène bovin et les compositions qui les contiennent
WO1990004642A1 (fr) Procede d'isolement d'interleukine-2 glycosylee et interleukine-2 glycosylee
WO1981000847A1 (fr) Peptides ayant des proprietes immunostimulantes et compositions pharmaceutiques les contentant
EP0419298A1 (fr) Protéines immunostimulantes, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et application de ces produits à des fins thérapeutiques et de diagnostic
EP0198878A1 (fr) Application du diethyldithiocarbamate (dtc) a la preparation d'un medicament et son procede de preparation.
EP0153710A2 (en) Novel toxoids of elastase of pseudomonas aeruginosa origin
FR2532850A1 (fr) Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention
FR2731355A1 (fr) Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
CN109535247A (zh) 聚乙二醇修饰的藻蓝蛋白及其制备方法与制药应用
EP1137433B1 (en) Pharmaceutical compositions containing protein-disulfide isomerases
EP0139555A1 (fr) Nouveau peptide de synthèse, son procédé de préparation et médicaments le contenant